Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Form: Lyophilized powder
Unit Size: 10mg total (5mg CJC-1295 w/o DAC + 5mg Ipamorelin per vial)
Storage: Store lyophilized at –20°C. After reconstitution, refrigerate at 2–8°C. Protect from light and moisture.
This blend combines two well-characterized peptides frequently utilized in laboratory settings to explore growth hormone secretagogue pathways:
CJC-1295 (w/o DAC) is a tetrasubstituted peptide analogue of growth hormone–releasing hormone (GHRH). The “without DAC” modification provides a shorter half-life, allowing study of pulsatile GH release models.
Ipamorelin is a selective ghrelin receptor agonist studied for its ability to stimulate GH release in vitro without significantly affecting prolactin or cortisol pathways.
Together, this blend offers researchers a complementary model system for investigating GH-related signaling and cellular responses.
Form: Lyophilized powder
Unit Size: 10mg total (5mg CJC-1295 w/o DAC + 5mg Ipamorelin per vial)
Storage: Store lyophilized at –20°C. After reconstitution, refrigerate at 2–8°C. Protect from light and moisture.
This blend combines two well-characterized peptides frequently utilized in laboratory settings to explore growth hormone secretagogue pathways:
CJC-1295 (w/o DAC) is a tetrasubstituted peptide analogue of growth hormone–releasing hormone (GHRH). The “without DAC” modification provides a shorter half-life, allowing study of pulsatile GH release models.
Ipamorelin is a selective ghrelin receptor agonist studied for its ability to stimulate GH release in vitro without significantly affecting prolactin or cortisol pathways.
Together, this blend offers researchers a complementary model system for investigating GH-related signaling and cellular responses.